Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Inkwood Research | PRODUCT CODE: 1329832

Cover Image

PUBLISHER: Inkwood Research | PRODUCT CODE: 1329832

Thailand Neurovascular Devices/interventional Neurology Market Forecast 2023-2030

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 1100
PDF & Excel (Corporate License)
USD 1500

Add to Cart

KEY FINDINGS

The Thailand neurovascular devices/interventional neurology market is projected to rise with a CAGR of 6.23% during the forecast years. The country's market growth is fuelled by the increasing geriatric population as well as the surging rates of Alzheimer's disease. The base year considered for the studied market is 2022, and the forecasting period is between 2023 to 2030.

MARKET INSIGHTS

Stroke poses a major health burden in Thailand, ranking as the leading cause of death and long-term disability in both men and women. Its prevalence is estimated to be 1.88% among adults aged 45 and older, with a higher incidence in men and an average onset age of 65 years. These compelling factors are poised to drive further expansion in the neurovascular disorder treatment market in Thailand. As the demand for specialized care and advanced treatments increases, the country's healthcare sector will play a crucial role in addressing the challenges posed by these neurological conditions.

Alzheimer's disease is becoming increasingly prevalent in Thailand, impacting approximately 3-5% of the population, with dementia-related deaths accounting for 5.13% of total mortality. Future projections indicate that by 2030, the number of Alzheimer's patients in Thailand will soar to 1,117,000. This alarming trend is fueling a substantial surge in the demand for effective treatments to address this neurodegenerative disorder. Thus, such factors are set to bolster the Thailand neurovascular devices/interventional neurology market growth over the forecast period.

COMPETITIVE INSIGHTS

Leading enterprises operating in the market include: Johnson & Johnson (Cerenovus), Balt, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 67104

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. METHODOLOGY
  • 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. SCOPE OF STUDY
  • 2.5. CRISIS SCENARIO ANALYSIS
    • 2.5.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
  • 2.6. MAJOR MARKET FINDINGS
    • 2.6.1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
    • 2.6.2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
    • 2.6.3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS
    • 3.1.2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
    • 3.1.3. GERIATRIC POPULATION'S VULNERABILITY TO NEUROVASCULAR DISEASES
    • 3.1.4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
    • 3.2.2. LACK OF TRAINED NEUROSURGEONS

4. KEY ANALYTICS

  • 4.1. KEY MARKET TRENDS
  • 4.2. PORTER'S FIVE FORCES ANALYSIS
    • 4.2.1. BUYERS POWER
    • 4.2.2. SUPPLIERS POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. GROWTH PROSPECT MAPPING
    • 4.3.1. GROWTH PROSPECT MAPPING FOR THAILAND
  • 4.4. MARKET CONCENTRATION ANALYSIS
  • 4.5. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT

  • 5.1. EMBOLIZATION DEVICES
    • 5.1.1. EMBOLIC COILS
      • 5.1.1.1. COATED DETACHABLE COILS
      • 5.1.1.2. BARE DETACHABLE COILS
    • 5.1.2. COIL ASSIST STENT
    • 5.1.3. CLIPPINGS
    • 5.1.4. COIL ASSIST BALLOON
  • 5.2. ACCESSORY DEVICES
    • 5.2.1. MICROCATHETERS
    • 5.2.2. MICRO GUIDEWIRES
  • 5.3. REVASCULARIZATION DEVICES
    • 5.3.1. CAROTID ARTERY STENTS
    • 5.3.2. FLOW DIVERSION STENTS
  • 5.4. THROMBECTOMY DEVICES
    • 5.4.1. CLOT RETRIEVAL DEVICES
    • 5.4.2. SUCTION AND ASPIRATION DEVICES
    • 5.4.3. SNARES
  • 5.5. EMBOLIC PROTECTION DEVICES
    • 5.5.1. BALLOON OCCLUSION DEVICES
    • 5.5.2. DISTAL FILTER DEVICES

6. MARKET BY APPLICATION

  • 6.1. ANEURYSM
  • 6.2. ISCHEMIC STROKE
  • 6.3. STENOSIS
  • 6.4. ARTERIOVENOUS MALFORMATION (AVM)
  • 6.5. OTHER APPLICATIONS

7. COMPETITIVE LANDSCAPE

  • 7.1. KEY STRATEGIC DEVELOPMENTS
    • 7.1.1. MERGERS & ACQUISITIONS
    • 7.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 7.1.3. PARTNERSHIPS & AGREEMENTS
    • 7.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 7.2. COMPANY PROFILES
    • 7.2.1. ACANDIS GMBH
      • 7.2.1.1. COMPANY OVERVIEW
      • 7.2.1.2. PRODUCT LIST
    • 7.2.2. BALT
      • 7.2.2.1. COMPANY OVERVIEW
      • 7.2.2.2. PRODUCT LIST
    • 7.2.3. JOHNSON & JOHNSON (CERENOVUS)
      • 7.2.3.1. COMPANY OVERVIEW
      • 7.2.3.2. PRODUCT LIST
      • 7.2.3.3. STRENGTHS & CHALLENGES
    • 7.2.4. MEDTRONIC INC
      • 7.2.4.1. COMPANY OVERVIEW
      • 7.2.4.2. PRODUCT LIST
      • 7.2.4.3. STRENGTHS & CHALLENGES
    • 7.2.5. PHENOX INC
      • 7.2.5.1. COMPANY OVERVIEW
      • 7.2.5.2. PRODUCT LIST
      • 7.2.5.3. STRENGTHS & CHALLENGES
    • 7.2.6. STRYKER CORPORATION
      • 7.2.6.1. COMPANY OVERVIEW
      • 7.2.6.2. PRODUCT LIST
      • 7.2.6.3. STRENGTHS & CHALLENGES
    • 7.2.7. TERUMO CORPORATION
      • 7.2.7.1. COMPANY OVERVIEW
      • 7.2.7.2. PRODUCT LIST
      • 7.2.7.3. STRENGTHS & CHALLENGES
Product Code: 67104

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY
  • TABLE 2: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 3: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 4: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 5: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 6: THAILAND EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 7: THAILAND EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 8: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 9: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 10: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 11: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 12: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 13: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 14: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 15: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 16: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, HISTORICAL YEARS 2018-2022 (IN $ MILLION)
  • TABLE 17: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, FORECAST YEARS 2023-2030 (IN $ MILLION)
  • TABLE 18: LIST OF MERGERS & ACQUISITIONS
  • TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: GROWTH PROSPECT MAPPING FOR THAILAND
  • FIGURE 4: MARKET CONCENTRATION ANALYSIS
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022
  • FIGURE 7: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 8: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIZATION DEVICES, IN 2022
  • FIGURE 9: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC COILS, 2023-2030 (IN $ MILLION)
  • FIGURE 10: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC COILS, IN 2022
  • FIGURE 11: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COATED DETACHABLE COILS, 2023-2030 (IN $ MILLION)
  • FIGURE 12: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BARE DETACHABLE COILS, 2023-2030 (IN $ MILLION)
  • FIGURE 13: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST STENT, 2023-2030 (IN $ MILLION)
  • FIGURE 14: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLIPPINGS, 2023-2030 (IN $ MILLION)
  • FIGURE 15: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST BALLOON, 2023-2030 (IN $ MILLION)
  • FIGURE 16: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 17: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY ACCESSORY DEVICES, IN 2022
  • FIGURE 18: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICROCATHETERS, 2023-2030 (IN $ MILLION)
  • FIGURE 19: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICRO GUIDEWIRES, 2023-2030 (IN $ MILLION)
  • FIGURE 20: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 21: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY REVASCULARIZATION DEVICES, IN 2022
  • FIGURE 22: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CAROTID ARTERY STENTS, 2023-2030 (IN $ MILLION)
  • FIGURE 23: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY FLOW DIVERSION STENTS, 2023-2030 (IN $ MILLION)
  • FIGURE 24: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 25: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY THROMBECTOMY DEVICES, IN 2022
  • FIGURE 26: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLOT RETRIEVAL DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 27: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SUCTION AND ASPIRATION DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 28: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SNARES, 2023-2030 (IN $ MILLION)
  • FIGURE 29: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 30: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC PROTECTION DEVICES, IN 2022
  • FIGURE 31: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BALLOON OCCLUSION DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 32: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISTAL FILTER DEVICES, 2023-2030 (IN $ MILLION)
  • FIGURE 33: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
  • FIGURE 34: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ANEURYSM, 2023-2030 (IN $ MILLION)
  • FIGURE 35: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ISCHEMIC STROKE, 2023-2030 (IN $ MILLION)
  • FIGURE 36: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY STENOSIS, 2023-2030 (IN $ MILLION)
  • FIGURE 37: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2023-2030 (IN $ MILLION)
  • FIGURE 38: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY OTHER APPLICATIONS, 2023-2030 (IN $ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!